APA (7th ed.) Citation

Y, C., KY, C., J, S., CM, C., & HM, L. (2026). Association of GLP-1 Receptor Agonist Use With Risk of Lumbar Degenerative Disease and Spine Surgery in Patients With Type 2 Diabetes: A Propensity Score-matched Cohort Study. Global spine journal, 16(3), 1418. https://doi.org/10.1177/21925682251383170

Chicago Style (17th ed.) Citation

Y, Chang, Chi KY, Song J, Chen CM, and Lin HM. "Association of GLP-1 Receptor Agonist Use With Risk of Lumbar Degenerative Disease and Spine Surgery in Patients With Type 2 Diabetes: A Propensity Score-matched Cohort Study." Global Spine Journal 16, no. 3 (2026): 1418. https://doi.org/10.1177/21925682251383170.

MLA (9th ed.) Citation

Y, Chang, et al. "Association of GLP-1 Receptor Agonist Use With Risk of Lumbar Degenerative Disease and Spine Surgery in Patients With Type 2 Diabetes: A Propensity Score-matched Cohort Study." Global Spine Journal, vol. 16, no. 3, 2026, p. 1418, https://doi.org/10.1177/21925682251383170.